NUGS Stock Overview
Engages in the cultivation of marijuana products in the United States. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cannabis Strategic Ventures Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0003 |
52 Week Low | US$0.000001 |
Beta | 0 |
11 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
33 Year Change | -100.00% |
5 Year Change | -100.00% |
Change since IPO | -99.98% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
NUGS | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | 0% | 3.4% | 1.6% |
1Y | 0% | 14.2% | 32.3% |
Return vs Industry: NUGS underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.
Return vs Market: NUGS underperformed the US Market which returned 32.4% over the past year.
Price Volatility
NUGS volatility | |
---|---|
NUGS Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 10.0% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 16.2% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NUGS's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine NUGS's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Simon Yu | www.cannabisstrategic.com |
Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.
Cannabis Strategic Ventures Fundamentals Summary
NUGS fundamental statistics | |
---|---|
Market cap | US$404.00 |
Earnings (TTM) | -US$5.64m |
Revenue (TTM) | US$14.60m |
0.0x
P/S Ratio0.0x
P/E RatioIs NUGS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
NUGS income statement (TTM) | |
---|---|
Revenue | US$14.60m |
Cost of Revenue | US$11.81m |
Gross Profit | US$2.78m |
Other Expenses | US$8.42m |
Earnings | -US$5.64m |
Last Reported Earnings
Mar 31, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did NUGS perform over the long term?
See historical performance and comparison